• Home
  • About Us
  • Blog

Pulmonary Hypertension RN

  • What is Pulmonary Hypertension?
    • What is Pulmonary Hypertension?
    • Pulmonary Hypertension Symptoms
    • Types of Pulmonary Hypertension
    • Causes of Pulmonary Hypertension
    • PH vs. PAH
    • Diastolic Heart Failure vs. PAH
    • WHO Group 3 Pulmonary Hypertension, IPF & COPD
    • Pulmonary Veno-Occlusive Disease
    • Hereditary Hemorrhagic Telangiectasia (HHT)
      • Hereditary Hemorrhagic Telangiectasia (HHT) Treatment
    • Functional Classification of Pulmonary Hypertension
    • Congenital Heart Disease
      • Eisenmenger’s Syndrome
      • Update on Management of PAH-CHD
      • Congenital Heart Disease & Sleep Apnea
      • Complex Congenital Heart Disease
      • Atrial Septal Defect and Pulmonary Arterial Hypertension
    • Pediatric Pulmonary Arterial Hypertension
    • Sickle Cell and Pulmonary Hypertension
    • Stimulant Associated Pulmonary Arterial Hypertension
    • Porto-Pulmonary Syndrome
    • Research, Life Expectancy & Prognosis for PH
  • Diagnosing & Monitoring PAH
    • Pulmonary Arterial Hypertension Diagnosis
    • How Am I Doing? Assessing Your PAH.
    • Blood Tests
    • Cardiopulmonary Exercise Test (CPET)
    • CT (Computed Tomography) Scan
    • Echocardiogram: An Overview
    • Echocardiogram: A Detailed Look
    • Pulmonary Function Tests (PFTs)
    • Right Heart Catheterization
    • Six Minute Walk
    • Ventilation Perfusion Scan (VQ Scan)
    • CTEPH
      • CTEPH: WHO Group 4 Pulmonary Hypertension
      • PTE (Pulmonary Thromboendarterectomy) Surgery
      • Adempas used to Treat PAH and CTEPH
  • PAH Treatment
    • Pulmonary Hypertension Centers
    • Pulmonary Hypertension Treatments
    • Continuously Infused Therapies Used to Treat PH
    • Prostanoids for Treatment of PH
    • Adcirca and Revatio Used to Treat Pulmonary Arterial Hypertension (PAH)
    • Adempas used to Treat PAH and CTEPH
    • Tracleer, Letairis, and Opsumit Treatments
    • Oxygen Therapy for Pulmonary Hypertension
    • Salt and Water Restrictions
    • Exercise & PAH
    • Diuretics
    • Blood Thinners
    • Getting the Most Out of PAH Therapy
      • Letairis
      • Opsumit
      • Sildenafil (Revatio)
  • Research
  • FAQ’s
    • Implanted Remodulin Pump, Right Heart Catheterization, PAH & Pregnancy
    • Oral Treatments, Care Centers & Hole in Heart
    • FAQ’s: Altitude, Cold & Allergy Medications
    • FAQ’s: Psoriasis, Idiopathic PAH, Contraceptives & PAH
    • FAQ’s: Causes of Pulmonary Hypertension, Symptom Frequency & Care Centers
    • FAQ: PAH Experts, Pregnancy, Mild PAH & Vacationing
    • FAQ’s: CTEPH, Blood Clots, Corrective Surgery & PAH Care Centers
    • FAQ’s: VQ Scans & PAH Curable?
    • FAQ’s: Mild Pulmonary Hypertension?
    • FAQ’s: Boating, Swimming & Eating with PAH
    • FAQ’s: Borderline Pulmonary Hypertension, Hand Swelling, Children with PAH, Costs

WHO Group 3 Pulmonary Hypertension, IPF & COPD

Pulmonary hypertension can develop from disease process intrinsic to the pulmonary arteries (Group I disease or PAH), or from diseases of the left side of the heart (Group II Pulmonary Hypertension), or from lung tissue disease processes (Group III Pulmonary Hypertension). This page will focus on pulmonary hypertension caused by lung parenchyma (lung tissue) diseases.

Idiopathic Pulmonary Fibrosis and Pulmonary Hypertension

PH related to lung diseaseThe two most common lung diseases that lead to elevated pulmonary artery pressures are COPD (emphysema or chronic bronchitis) and Idiopathic Pulmonary Fibrosis (IPF). With progressive lung tissue disease, there is gradual loss of blood vessels, chronic low oxygen levels and a gradual increase in the pulmonary artery pressure. Over time, the higher pulmonary artery pressures result in the right side of the heart working harder and harder to pump blood through the pulmonary arteries. Eventually, the right side of the heart begins to dilate (enlarge) and patients begin to retain fluid (this is the beginning of right heart failure). At this time, patients notice leg swelling and perhaps abdominal swelling. Without treatment, this is a progressive decline. However, IPF treatments can improve symptoms and improve exercise capacity.

COPD and Pulmonary Hypertension

COPD is one of the most common adult lung diseases. The vast majority of patients smoked cigarettes for more than 10 years. Occasionally, a patient may have COPD from chronic exposure to very poor air quality such as in a factory or related to a rare genetic disease called alpha-1 anti-trypsin deficiency. Symptoms begin slowly with cough, sputum, wheeze and progressive exercise intolerance. The disease is diagnosed by pulmonary function testing. High resolution CT scanning of the chest can diagnose emphysema as well. Treatments focus on inhaled medications that improve air flow through the airways. Smoking cessation is paramount.

Mild pulmonary hypertension is common in COPD but severe pulmonary hypertension is quite uncommon. The echocardiogram is particularly poor at estimating pulmonary artery pressures in patients with lung disease and right heart catheterization is required. Patients with mild elevations in pulmonary artery pressure do not require specific treatments targeting pulmonary hypertension. Diuretics are often used to treat fluid retention. Oxygen and inhaled medications are used to maximally treat low oxygen levels and airflow obstruction. Occasionally a patient will have very severe pulmonary hypertension associated with COPD. In these situations we will carefully embark on a treatment course with PAH medications. We avoid endothelin receptor antagonists as they have been found not to be beneficial. There is some limited data that PDE 5 inhibitors may be helpful. Some patients that are treated with pulmonary hypertension medications will paradoxically do worse due to worsening oxygen levels.

PAH Life Expectancy

PAH Research

Research, Life Expectancy & Prognosis for PH

Major Developments in Pulmonary Hypertension Affecting Prognosis 1.     Approval of

Where to Get Treatment?

CCCs for PAH

Pulmonary Hypertension Centers

Where to get treatment for pulmonary hypertension? Pulmonary arterial hypertension is a

Popular Posts

Pulmonary hypertension and pregnancy

Pregnancy and Pulmonary Hypertension Part 2

By Dr. Jeremy Feldman

The literature has described the risk of pregnancy to the mother as very severe in patients with advanced PAH. 

PAH Caregiver

3 Awesome Resources for Caregivers of PH Patients

By Dr. Jeremy Feldman

Pulmonary arterial hypertension is a terrifying and debilitating disease that affects not only patients but also their

good news in pah

 

Disclaimer

Recent Blog Posts

  • In Memoriam:  Greg Ahearn, MD June 16, 2024
  • Sotatercept (Winrevair) Approved! June 1, 2024
  • Disappointing News for Rodatristat Ethyl October 11, 2023

Categories

Archives